GeneSpector Innovations presents a solution for simple and reliable next-generation nucleic acid sequencing for various diagnostic applications feasible in any laboratory.

Presented solution is based on an innovative approach for designing custom set of oligonucleotides for an effortless, amplicon-based sequencing of target DNA or RNA that is compatible with all types of sequencing platforms. Applications range from sequencing of viral genomes of new strands, such as different SARS-CoV-2 variants, to diagnosis of genetic disorders.

We are working tirelessly together with our academic and commercial partners to have this solution market-ready by 2023.